EU for Evibodies

By Kate McDonald
Monday, 09 February, 2009

Arana Therapeutics has been granted an EU patent for its Evibodies range of small antibodies.

Evibodies were part of the technology platform brought into the company by EvoGenix when it merged with Peptech in 2007.

Evibodies are small fragments of a family of proteins that act like antibodies but are about one-tenth smaller.

They were given a US patent in 2007.

The new 4500 sqm RNA Research and Manufacturing Facility within the Macquarie University...

To support immune cell therapy products for the treatment of cancer and endometriosis, Australian...

Launched this week, the Barwon Health–Deakin University Clinical Trials Alliance is...

Content from other channels on our network

Australian National Campylobacter Action Plan, call to register interest

New rules for caffeinated products

Are consumers ready for food made from seafood sidestreams?

50 Years Strong: Celebrating Linco Food Systems in Australia (1975–2025)

Innovations in inspection solutions for meat, poultry and seafood

Belden demonstrates 5G industrial switch

Federal government invests in solid rocket motor manufacturing

Measurement Solutions joins the Bestech Group: a significant step into the process industries

Supply chain dependencies pose risks to renewable energy goals: study

Building grid resilience with quantum timing

Renewables supply reaches almost 50% on Aust's east coast

Quantum timing study to help future-proof energy grid

New method to extract microplastics from soil: study

Water treatment plant receives 'Blue Loan'

Australians need to take care when recycling